Drug Profile
Bevacizumab biosimilar - Apobiologix
Alternative Names: BambeviLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Apobiologix
- Class Antineoplastics; Eye disorder therapies; Immunotherapies; Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Brain cancer; Colorectal cancer; Lung cancer; Ovarian cancer